PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.36
Negative P/E while Healthcare median is -1.57. Seth Klarman would scrutinize path to profitability versus peers.
11.96
P/S exceeding 1.5x Healthcare median of 7.57. Jim Chanos would check for potential multiple compression risks.
0.51
P/B less than half the Healthcare median of 1.82. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-89.38
Negative FCF while Healthcare median P/FCF is -4.92. Seth Klarman would investigate cash flow improvement potential.
-93.49
Negative operating cash flow while Healthcare median P/OCF is -3.58. Seth Klarman would investigate operational improvement potential.
0.51
Fair value ratio less than half the Healthcare median of 1.84. Joel Greenblatt would investigate if this discount is justified.
-68.64%
Negative earnings while Healthcare median yield is -2.58%. Seth Klarman would investigate path to profitability.
-1.12%
Negative FCF while Healthcare median yield is -1.29%. Seth Klarman would investigate cash flow improvement potential.